# Reversing the Effects of 0.5% Bupivacaine

> **NCT02995291** · PHASE4 · COMPLETED · sponsor: **Dalhousie University** · enrollment: 44 (actual)

## Conditions studied

- Anesthesia, Local

## Interventions

- **DRUG:** OraVerse
- **DRUG:** Saline Water (Control)

## Key facts

- **NCT ID:** NCT02995291
- **Lead sponsor:** Dalhousie University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-10
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-09-15
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02995291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02995291, "Reversing the Effects of 0.5% Bupivacaine". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02995291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*